Roche CEO Severin Schwan is keeping his hand on the budget ax

Just a few weeks after Roche brought out the ax and chopped more than 200 jobs out of Genentech in an unusual cost-cutting move in R&D for the pharma giant, CEO Severin Schwan is likely raising some added tensions with a pledge to root out inefficiencies.

In an interview with Reuters that will be closely read today by the rank and file, Schwan said that the company is streamlining its global business units in a move that will affect “scores of jobs.”